Kimberg D V, Field M, Gershon E, Schooley R T, Henderson A
J Clin Invest. 1973 Jun;52(6):1376-83. doi: 10.1172/JCI107310.
Prior studies have indicated that effects of cholera enterotoxin (CT) on the small intestine are delayed in onset and involve an interaction with adenyl cyclase in the mucosa. It has also been shown that the administration of cycloheximide to rabbits in doses which inhibit crypt cell mitoses (20 mg/kg), diminishes CT-induced fluid production in jejunal loops. These latter studies have been interpreted as indications that CT-related intestinal secretion is a crypt cell function and that it is mediated by a CT-induced protein. The present study was undertaken to delineate more precisely the nature of the interaction in the intestine between cycloheximide and cholera toxin. Pretreatment of rabbits with cycloheximide reduced by 60% the secretory response to CT in isolated ileal loops with intact blood supply. Sodium and chloride flux measurements on mucosa isolated from these and control loops indicated that this antisecretory effect of cycloheximide persists in vitro. Measurements of radioactive leucine incorporation into mucosal protein indicated that the dose of cycloheximide employed inhibited protein synthesis by 90%. This inhibitory effect was shown to be independent of any effect of cycloheximide on amino acid uptake across the brush border. Measurements of adenyl cyclase activity and cyclic AMP levels in ileal mucosa of cycloheximide pretreated and control animals indicated that cycloheximide did not diminish the CT-induced increases in these parameters. These observations demonstrate that cycloheximide reduces CT-induced intestinal fluid production without interfering with the CT-induced augmentation of adenyl cyclase activity or the consequent rise in cyclic. AMP concentration. Since the antisecretory effect of cycloheximide persists in vitro, it probably involves a direct interaction of the antibiotic with mucosal cell ion transport mechanisms rather than an indirect effect mediated by other humoral or neurogenic factors. The present observations also suggest that the secretory response of the intestine to CT involves neither the synthesis of new adenyl cyclase nor that of a protein modifying its activity.
先前的研究表明,霍乱肠毒素(CT)对小肠的作用起效延迟,且涉及与黏膜中腺苷酸环化酶的相互作用。研究还表明,给兔子注射能抑制隐窝细胞有丝分裂的剂量的环己酰亚胺(20毫克/千克),可减少CT诱导的空肠肠袢液体分泌。后一项研究被解释为表明与CT相关的肠道分泌是隐窝细胞的功能,且由CT诱导的一种蛋白质介导。本研究旨在更精确地描述环己酰亚胺与霍乱毒素在肠道中的相互作用性质。用环己酰亚胺预处理兔子后,在有完整血液供应的离体回肠肠袢中,对CT的分泌反应降低了60%。对从这些肠袢和对照肠袢分离出的黏膜进行钠和氯通量测量表明,环己酰亚胺的这种抗分泌作用在体外持续存在。对放射性亮氨酸掺入黏膜蛋白的测量表明,所用剂量的环己酰亚胺抑制蛋白质合成达90%。已证明这种抑制作用与环己酰亚胺对通过刷状缘摄取氨基酸的任何作用无关。对用环己酰亚胺预处理和对照动物的回肠黏膜中腺苷酸环化酶活性和环磷酸腺苷水平的测量表明,环己酰亚胺并未减少CT诱导的这些参数的增加。这些观察结果表明,环己酰亚胺可减少CT诱导的肠道液体分泌,而不会干扰CT诱导的腺苷酸环化酶活性增强或随之而来的环磷酸腺苷浓度升高。由于环己酰亚胺的抗分泌作用在体外持续存在,它可能涉及抗生素与黏膜细胞离子转运机制的直接相互作用,而不是由其他体液或神经源性因素介导的间接作用。目前的观察结果还表明,肠道对CT的分泌反应既不涉及新腺苷酸环化酶的合成,也不涉及改变其活性的蛋白质的合成。